Table 5

Suggested monitoring for patients with CVID*

PatientsTypeInterval
All Interval history, physical examination, height and weight 12 months 
Complete blood counts: Hgb, Hct, white blood cells and differential, platelets, and chemistry panel, including liver and kidney functions; albumin 12 months 
serum IgG* 6-12 months or with weight gain, pregnancy 
Chest x-ray Referral 
Spirometry 12 months 
With lung disease High-resolution chest computed tomography 3-4 years or after change of therapy 
Complete lung functions with carbon monoxide diffusion 12 months 
With gastrointestinal complications Upper and/or lower endoscopy Intervals as required for optimum treatment 
With evidence of malabsorption, including loss of height (women in particular) Bone density, evaluation of nutrients As dictated by the therapy used 
PatientsTypeInterval
All Interval history, physical examination, height and weight 12 months 
Complete blood counts: Hgb, Hct, white blood cells and differential, platelets, and chemistry panel, including liver and kidney functions; albumin 12 months 
serum IgG* 6-12 months or with weight gain, pregnancy 
Chest x-ray Referral 
Spirometry 12 months 
With lung disease High-resolution chest computed tomography 3-4 years or after change of therapy 
Complete lung functions with carbon monoxide diffusion 12 months 
With gastrointestinal complications Upper and/or lower endoscopy Intervals as required for optimum treatment 
With evidence of malabsorption, including loss of height (women in particular) Bone density, evaluation of nutrients As dictated by the therapy used 

CVID indicates common variable immune deficiency; Hct, hematocrit; Hgb, hemoglobin; IgA, immunoglobulin A; IgG, immunoglobulin G; and IgM; immunoglobulin M.

*

Consider adding also serum IgA or IgM if there is a question about the stability of the diagnosis or onset of other complications.

Close Modal

or Create an Account

Close Modal
Close Modal